iGaming Supplier Tweets (Powered By Twitter)

What India needs is not more isolated facilities, but a mission that integrates institutions across disciplines and offers industry a seamless, single-window platform for testing, validation and innovation: Dr Shailaja Donempudi, Distinguished Scientist and Head, Business Development Group, Council of Scientific and Industrial Research (CSIR) while addressing the session on 'Efficient utilisation of existing Testing Lab Infrastructure for Medical Device Industry' at 9th edition of #IndiaMedicalDevice2026 Department of Pharmaceuticals 🇮🇳

In India there are around 90 Medical Device Testing Laboratories (MDTLs) including laboratories supporting in vitro diagnostics, and this number is increasing day by day: Mr Pramod Meshram, Deputy Drugs Controller (India), IVD Division, CDSCO, GoI while addressing the session on 'Efficient utilisation of existing Testing Lab Infrastructure for Medical Device Industry' at 9th edition of #IndiaMedicalDevice2026 Department of Pharmaceuticals 🇮🇳

Mr Ritesh Kumar, Senior Director, Global Core Sales & Country Lead – India, Wiley, will speak at the session on 'Research Integrity: Safeguarding Scholarly Publishing' at PubliCon 2026. The session will focus on fostering research integrity, strengthening quality and trust in scholarly communication, and addressing emerging challenges through responsible publishing practices and innovation. 📅 10 August 2026 | 📍 FICCI, New Delhi Scan QR code or register now - meet.ficci.in/invitee-form.a… #PubliCon2026 #Publishing #ArtificialIntelligence #ScholarlyPublishing #ResearchIntegrity #SpringerNature #FICCI

Mr Venkatesh Sarvasiddhi, Managing Director, Royal Society of Chemistry, will moderate the session on 'The Future of Scholarly Communication and Knowledge Dissemination' at PubliCon 2026. The session will focus on evolving models of scholarly communication, open access and open science, enhancing the visibility and impact of research, and strengthening collaboration across the global research and publishing ecosystem. 📅 10 August 2026 | 📍 FICCI, New Delhi Scan QR code or register now - meet.ficci.in/invitee-form.a… #PubliCon2026 #Publishing #ArtificialIntelligence #ScholarlyPublishing #ResearchIntegrity #SpringerNature #FICCI

Collaboration is the key to success for the Indian medical devices industry. The road to Viksit Bharat comes from a healthy Bharat: Mr Bharath Sesha, Co-Chair, FICCI Medical Devices Committee and Managing Director, Philips Indian Subcontinent at 9th edition of #IndiaMedicalDevice2026 Department of Pharmaceuticals 🇮🇳

There is a need to improve quality of medical devices being developed in India and the goal should be to not only cater to India but the global market. A strategic shift is needed to make this happen. Unless the component industry for medical devices is developed in India, the imports of medical devices will not go down: Mr Manoj Joshi, Secretary, Department of Pharmaceuticals 🇮🇳 , Government of India at 9th edition of #IndiaMedicalDevice2026

RT Department of Pharmaceuticals 🇮🇳: India Medical Device 2026 commenced with the traditional Lamp Lighting Ceremony, marking the beginning of two days of meani…

FICCI- Dua Consulting knowlege paper on ‘Strengthening of Service and Maintenance of Medical Equipment in India’ released by the dignitaries at 9th edition of #IndiaMedicalDevice2026 https://t.co/V8hIAFTKO4

Achieving India’s ambition of becoming a global hub for medical devices will require continued focus on innovation, domestic manufacturing, clinical evidence generation, quality infrastructure, AI enabled technologies, export competitiveness and sustainable healthcare assist: Mr Tushar Sharma, Chair, FICCI Medical Devices Committee and Managing Director & GM, India & South Asia, Abbott Healthcare at 9th edition of #IndiaMedicalDevice2026 Department of Pharmaceuticals 🇮🇳

Imports of medical devices have grown with CAGR of 1% only from 2022 to 2025 and the CAGR of domestic production is 43%. This data shows that we are moving from import driven industry towards a domestic manufacturing driven industry, and that is exactly what the country’s policies and regulatory systems are working towards: Dr Rajeev Singh Raghuvanshi, Drugs Controller General of India (DCGI) at 9th edition of #IndiaMedicalDevice2026 Department of Pharmaceuticals 🇮🇳

Medical technology not only enables better clinical outcomes but also strengthens national healthcare resilience, drives industrial growth, creates high-skilled employment and contributes to India's growing presence in global value chains: Ms jyoti vij , Director General, FICCI at 9th edition of India Medical Device 2026 #IndiaMedicalDevice2026 Department of Pharmaceuticals 🇮🇳

x.com/i/article/2085…

Day 1 of the 9th edition of India Medical Device 2026 on the theme 'Towards Viksit Bharat: Advancing India as a Global Hub for Quality Medical Devices' begins at New Delhi. https://t.co/2SmirA8K8L

RT Department of Pharmaceuticals 🇮🇳: India Medical Device 2026 commenced with the traditional Lamp Lighting Ceremony, marking the beginning of two days of meani…

CreditSights upgraded its recommendation on Wynn Macau’s bonds to tactical Outperform from Market Perform. The change is an investment recommendation rather than an upgrade to the operator’s formal credit rating. agbrief.com/news/macau/06/…